GoJohnnyGo
One Badass Dude
http://www.medscape.com/viewarticle/731851
Still fairly early into the study, but what promising news!
Apparently, you need to subscribe to this link's site.
Without posting the entire article (copyright issues), here's the first few paragraphs.
Still fairly early into the study, but what promising news!
Apparently, you need to subscribe to this link's site.
Without posting the entire article (copyright issues), here's the first few paragraphs.
November 3, 2010 — An antibiotic currently indicated for hepatic encephalopathy and traveler's diarrhea has shown promise in the treatment of Crohn's disease (CD).
RETIC-03, a large phase 2 trial presented at the 18th Annual United European Gastroenterology Week in Barcelona, Spain, showed that rifaximin-EIR (extended intestinal release) was able to achieve clinical remission of Crohn's sequelae in up to 62% of patients out to 12 weeks, according to study investigator, Herbert Lochs, MD, from the Medical University in Innsbruck, Austria.
Last edited: